Nature Communications (Oct 2023)

Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis

  • Juliane Tschuck,
  • Lea Theilacker,
  • Ina Rothenaigner,
  • Stefanie A. I. Weiß,
  • Banu Akdogan,
  • Van Thanh Lam,
  • Constanze Müller,
  • Roman Graf,
  • Stefanie Brandner,
  • Christian Pütz,
  • Tamara Rieder,
  • Philippe Schmitt-Kopplin,
  • Michelle Vincendeau,
  • Hans Zischka,
  • Kenji Schorpp,
  • Kamyar Hadian

DOI
https://doi.org/10.1038/s41467-023-42702-8
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Ferroptosis is a regulated cell death modality that occurs upon iron-dependent lipid peroxidation. Recent research has identified many regulators that induce or inhibit ferroptosis; yet, many regulatory processes and networks remain to be elucidated. In this study, we performed a chemical genetics screen using small molecules with known mode of action and identified two agonists of the nuclear receptor Farnesoid X Receptor (FXR) that suppress ferroptosis, but not apoptosis or necroptosis. We demonstrate that in liver cells with high FXR levels, knockout or inhibition of FXR sensitized cells to ferroptotic cell death, whereas activation of FXR by bile acids inhibited ferroptosis. Furthermore, FXR inhibited ferroptosis in ex vivo mouse hepatocytes and human hepatocytes differentiated from induced pluripotent stem cells. Activation of FXR significantly reduced lipid peroxidation by upregulating the ferroptosis gatekeepers GPX4, FSP1, PPARα, SCD1, and ACSL3. Together, we report that FXR coordinates the expression of ferroptosis-inhibitory regulators to reduce lipid peroxidation, thereby acting as a guardian of ferroptosis.